Predictions
Abbott Laboratories
Start price
Target price
Perf. (%)
€85.17
14.08.20
14.08.20
€120.00
04.11.21
04.11.21
31.44%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€58.72
09.08.20
09.08.20
€65.00
26.08.20
26.08.20
-5.53%
26.08.20
26.08.20
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
04.08.20
04.08.20
€38.00
04.11.21
04.11.21
0.31%
13.04.21
13.04.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€89.92
30.07.20
30.07.20
€125.00
04.11.21
04.11.21
44.97%
21.01.21
21.01.21
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.70
16.07.20
16.07.20
€33.21
25.08.20
25.08.20
4.15%
25.08.20
25.08.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.65
12.07.20
12.07.20
-
17.10.20
17.10.20
9.93%
17.10.20
17.10.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.84
01.07.20
01.07.20
€42.69
08.07.20
08.07.20
-2.30%
08.07.20
08.07.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Baxter International
Start price
Target price
Perf. (%)
€77.61
01.07.20
01.07.20
€80.00
04.11.21
04.11.21
-12.10%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.48
19.06.20
19.06.20
€55.00
04.11.21
04.11.21
12.05%
04.04.21
04.04.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.87
08.06.20
08.06.20
€65.00
04.11.21
04.11.21
-18.67%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€264.80
05.06.20
05.06.20
€290.00
12.10.20
12.10.20
5.70%
12.10.20
12.10.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€66.80
20.05.20
20.05.20
€60.00
25.05.20
25.05.20
4.09%
25.05.20
25.05.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.59
03.05.20
03.05.20
€90.00
04.11.21
04.11.21
-25.71%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.31
30.04.20
30.04.20
€55.00
04.11.21
04.11.21
-24.47%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.45
30.04.20
30.04.20
€85.00
04.05.20
04.05.20
-5.28%
04.05.20
04.05.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.15
29.04.20
29.04.20
€90.00
04.11.21
04.11.21
-25.29%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€72.99
24.04.20
24.04.20
€85.00
04.11.21
04.11.21
-21.03%
05.11.21
05.11.21
Abbott Laboratories
Start price
Target price
Perf. (%)
€86.80
20.04.20
20.04.20
€120.00
04.11.21
04.11.21
28.11%
04.11.21
04.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
19.04.20
19.04.20
€80.00
04.11.21
04.11.21
-26.85%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€74.99
04.04.20
04.04.20
-
18.04.20
18.04.20
5.08%
18.04.20
18.04.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€81.44
31.03.20
31.03.20
€95.00
08.04.20
08.04.20
10.79%
08.04.20
08.04.20
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year